3.01
price down icon4.44%   -0.14
after-market アフターアワーズ: 3.11 0.10 +3.32%
loading
前日終値:
$3.15
開ける:
$3.15
24時間の取引高:
1.16M
Relative Volume:
1.17
時価総額:
$191.32M
収益:
$149.50M
当期純損益:
$-74.62M
株価収益率:
-2.5429
EPS:
-1.1837
ネットキャッシュフロー:
$-82.95M
1週間 パフォーマンス:
+2.38%
1か月 パフォーマンス:
-5.35%
6か月 パフォーマンス:
+121.32%
1年 パフォーマンス:
+104.76%
1日の値動き範囲:
Value
$2.97
$3.18
1週間の範囲:
Value
$2.90
$3.40
52週間の値動き範囲:
Value
$1.185
$3.88

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1111)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
293
Name
Twitter
@macrogenics
Name
次回の収益日
2026-05-12
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

Compare MGNX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MGNX icon
MGNX
Macrogenics Inc
3.01 200.21M 149.50M -74.62M -82.95M -1.1837
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
427.65 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
721.05 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
807.55 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
303.00 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
313.32 33.06B 5.36B 287.73M 924.18M 2.5229

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 アップグレード B. Riley Securities Neutral → Buy
2025-09-17 再開されました Barclays Overweight
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
May 05, 2026

MacroGenics and Sagard to expand Zynyz royalty purchase agreement - The Pharma Letter

May 05, 2026
pulisher
May 05, 2026

Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

May 05, 2026
pulisher
May 04, 2026

MacroGenics expands royalty deal with Sagard for $60M By Investing.com - Investing.com South Africa

May 04, 2026
pulisher
May 04, 2026

MacroGenics (MGNX) price target increased by 50.00% to 6.12 - MSN

May 04, 2026
pulisher
May 04, 2026

MacroGenics Expands ZYNYZ Royalty Agreement for Added Funding - TipRanks

May 04, 2026
pulisher
May 04, 2026

MacroGenics (Nasdaq: MGNX) secures $60M in expanded ZYNYZ royalty deal - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Incyte (INCY) Partners with MacroGenics in Expanded Royalty Agre - GuruFocus

May 04, 2026
pulisher
May 04, 2026

MacroGenics expands royalty deal with Sagard for $60M - Investing.com UK

May 04, 2026
pulisher
May 04, 2026

MacroGenics Expands ZYNYZ Royalty Deal With Sagard Healthcare Partners - Moomoo

May 04, 2026
pulisher
May 04, 2026

Macrogenics and Sagard Healthcare Partners enter into expanded Zynyz® Royalty Purchase Agreement - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

$60M now, up to $20M more: MacroGenics expands ZYNYZ deal - Stock Titan

May 04, 2026
pulisher
May 04, 2026

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement - Yahoo Finance

May 04, 2026
pulisher
May 04, 2026

MSN Money - MSN

May 04, 2026
pulisher
Apr 30, 2026

MSN - MSN

Apr 30, 2026
pulisher
Apr 29, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Short Interest Down 22.5% in April - MarketBeat

Apr 29, 2026
pulisher
Apr 27, 2026

MacroGenics gains removal of FDA partial hold on lead program - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

MacroGenics (MGNX) price target increased by 11.11% to 4.08 - MSN

Apr 27, 2026
pulisher
Apr 25, 2026

B Riley Securities upgrades MacroGenics (MGNX) - MSN

Apr 25, 2026
pulisher
Apr 25, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Apr 25, 2026
pulisher
Apr 23, 2026

MacroGenics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 23, 2026
pulisher
Apr 22, 2026

MacroGenics (MGNX) Stock Research | Q4 2025: EPS Beats ForecastsROIC - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026
pulisher
Apr 21, 2026

MGNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 21, 2026
pulisher
Apr 20, 2026

MGNX Maintains by Barclays -- Price Target Raised to $6.00 - GuruFocus

Apr 20, 2026
pulisher
Apr 20, 2026

Macrogenics Is Maintained at Overweight by Barclays - Moomoo

Apr 20, 2026
pulisher
Apr 20, 2026

MacroGenics Inc stock (US5562221046): Is its oncology pipeline strong enough to unlock new upside? - AD HOC NEWS

Apr 20, 2026
pulisher
Apr 18, 2026

MacroGenics Nears Key Prostate Cancer Catalyst as Phase 2 Lorigerlimab Trial Completes - TipRanks

Apr 18, 2026
pulisher
Apr 17, 2026

FDA Lifts Clinical Hold on MacroGenics Phase 2 Cancer Trial - HarianBasis.co

Apr 17, 2026
pulisher
Apr 17, 2026

B. Riley Sees Upside in MacroGenics, Inc. (MGNX) Following Gilead-Driven Sector Activity - Yahoo Finance

Apr 17, 2026
pulisher
Apr 16, 2026

MacroGenics (MGNX) Stock: Stabilizing? (Smart Money Outflows) 2026-04-16High Volume Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 16, 2026
pulisher
Apr 15, 2026

MacroGenics (MGNX) Stock Take Profit (Momentum Building) 2026-04-15Global Trading Community - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 15, 2026
pulisher
Apr 13, 2026

Recap Report: What is the next catalyst for MacroGenics IncQuarterly Profit Report & AI Enhanced Trading Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Sentiment Review: Whats the profit margin of MacroGenics Inc2026 Momentum Check & Real-Time Price Movement Reports - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

Today's Analyst Rating Data for MGNX: Major Upgrade by B. Riley Securities | MGNX Stock News - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Today's Analyst Rating Data for MGNX: Major Upgrade by B. Riley - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Macrogenics Inc Stock Historical Valuations | HAM:M55 - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Macrogenics Inc Stock Intrinsic Values | HAM:M55 - GuruFocus

Apr 10, 2026

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.82
price up icon 1.77%
$50.72
price up icon 0.56%
$95.26
price down icon 0.25%
$137.09
price down icon 1.69%
$151.07
price up icon 2.62%
ONC ONC
$313.32
price up icon 5.32%
大文字化:     |  ボリューム (24 時間):